MAR 25, 2019 10:59 AM PDT

Discovery of Biomarker Target for Melanoma

WRITTEN BY: Nouran Amin

According to a study published in the journal Cancer Research, researchers have discovered a biomarker that could serve as a possible therapeutic target for melanoma. The marker is microphthalmia-associated transcription factor (MITF)—which is is a protein that plays a crictcal role in the maintenance of the melanocyte lineage (cells that make melanin), as well as the differentiation of normal and malignant melanocytes and melanoma cell survival.

Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0

"We have now detected the first useful chemical inhibitor of MITF," said corresponding author Rhoda Alani, MD, the Herbert Mescon Chair of Dermatology at Boston University School of Medicine.

Over the past decade genetic mutations in human melanomas have been extensively examined—regardless, the role of epigenetic alterations in the development and progression of melanomas is still not well understood.

Specifically, scientists discovered that the inhibition of the epigenetic p300 Histone Acetyltransferase (HAT) enzyme stops the growth of human melanoma cells and cells that express the MITF protein are sensitive to this inhibition. The inhibition can hold many broad implications for the treatment of pigmented lesions in the skin which could potentially be used for the topical treatment of hyperpigmentation.

The study opens the doors to the endless pursuit for additional epigenetic approaches to cancers.

"When human melanoma cell lines were evaluated for growth effects using the chemical inhibitor of p300 HAT, the cell lines that were most sensitive to drug treatment were those that expressed high levels of MITF suggesting that MITF expression levels can predict melanoma sensitivity to such therapies," explained Alani, who also is chief of dermatology at Boston Medical Center.

Source: EurekAlert

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 26, 2018
Drug Discovery
DEC 26, 2018
Novel Water Approach May Improve Drug Design
An understanding of the basic molecular properties of water greatly influences drug design. But, a significant comprehension of water interactions and its ...
JAN 19, 2019
Drug Discovery
JAN 19, 2019
Therapeutic Avenues in Chronic Liver Disease
Known as being a silent killer, diagnosing chronic liver disease in its early stages remains a clinical challenge because of no apparent symptoms until the...
FEB 25, 2019
Drug Discovery
FEB 25, 2019
Photoelectrochemical Cells To Produce New Drug Discovery Molecules
Photoelectrochemical (PEC) cells utilize photocathodes and photoanodes to "split" water into hydrogen and oxygen. PEC cells have been primarily s...
MAR 13, 2019
Drug Discovery
MAR 13, 2019
Combination Immunotherapy Stops Liver Cancer Growth
The number of individuals diagnosed with liver cancer is on the rise and current therapies are largely ineffective. However, new preclinical data from the ...
MAR 31, 2019
Drug Discovery
MAR 31, 2019
Glowing Tumors Reveal How Immunotherapeutics Work
In a study published in the Journal of Clinical Investigation, researchers used positron emission tomography (PET) scans to examine how an immunotherapy dr...
APR 20, 2019
Drug Discovery
APR 20, 2019
How Exactly Does General Anesthesia Work?
General anesthesia is a medical miracle that enabled millions of patients to have life-saving surgeries without pain. However, despite the miraculous work ...
Loading Comments...